Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now

Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

May 12, 2021

BeiGene Highlights Progress in Hematology at EHA2021 Virtual Congress

May 7, 2021

China NMPA Approves PARP Inhibitor Pamiparib for Patients with Previously Treated Advanced Ovarian Cancer

May 6, 2021

BeiGene Reports First Quarter 2021 Financial Results

Key Metrics

Key Metrics

  • 5,400+


  • 1,600+

    Clinical team

  • 5


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.